Concepedia

Author

Weiping Deng

Moderna Therapeutics (United States)ORCID

Also Known As

David Dellaero, Deng, Wanxi, Holly Janes, Koup R.A, W Deng, W. Deng, W.P. Deng, WEIPING DENG, Wei-Ping Deng, Wei-ping Deng

162

Publications

6.3K

Citations

33

H-Index

91

Concepts

All Affiliations

Moderna Therapeutics (United States)Brigham and Women's HospitalDuke Medical CenterYunnan Agricultural UniversityBaylor College of Medicine
WD

About

Weiping Deng is an author at Moderna Therapeutics (United States) specializing in medicine, immunology, and virology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

21

2K

2

Engineering

2

2

70

3

Health Sciences

2

2

185

4

Public Health

2

2

78

5

Natural Sciences

1

1

17

Weiping Deng

×

68

Publications

5.9K

Citations

32

H-Index

YearCitations

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Peter B. Gilbert, David C. Montefiori, Adrian B. McDermott,

Science

2022

1.2K

Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial

Andreas Hochhaus, Giuseppe Saglio, Timothy P. Hughes,

Leukemia

2016

841

Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

Hana M. El Sahly, Lindsey R. Baden, Brandon Essink,

New England Journal of Medicine

2021

647

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study

Andreas Hochhaus, Tamás Masszi, Francis J. Giles,

Leukemia

2017

286

Whole-genome resequencing of 472 Vitis accessions for grapevine diversity and demographic history analyses

Zhenchang Liang, Shengchang Duan, Jun Sheng,

Nature Communications

2019

210

Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age

C. Buddy Creech, Evan J. Anderson, Vladimir Berthaud,

New England Journal of Medicine

2022

170

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

David M. Ross, Tamás Masszi, María Teresa Gómez‐Casares,

Journal of Cancer Research and Clinical Oncology

2018

140

Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial

Peter B. Gilbert, David C. Montefiori, Adrian B. McDermott,

2021

137

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age

Evan J. Anderson, C. Buddy Creech, Vladimir Berthaud,

New England Journal of Medicine

2022

136

Protective effects of hesperidin against oxidative stress of tert-butyl hydroperoxide in human hepatocytes

Mingcang Chen, Honggang Gu, Yiyi Ye,

Food and Chemical Toxicology

2010

118

Page 1